Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics. [PDF]
ACS Chem NeurosciBhat A +6 more
europepmc +1 more source
Molecular and Medical Aspects of Psychedelics. [PDF]
Int J Mol Sci, 2023 Wojtas A, Gołembiowska K.
europepmc +1 more source
Prolactinomas treated with dopaminergic agonists: behavior in different moments of life. [PDF]
Rev Bras Ginecol ObstetCarneiro MS +5 more
europepmc +1 more source
Natural Product-Inspired Dopamine Receptor Ligands. [PDF]
J Med ChemDorogan M, Namballa HK, Harding WW.
europepmc +1 more source
Novel Non-Hallucinogenic Compounds as 5‑HT2A Agonists for Treating Mental Health Disorders, Namely Depression, Anxiety, Stress Disorders, and Eating Disorders. [PDF]
ACS Med Chem LettSabnis RW.
europepmc +1 more source
Novel Non-hallucinogenic Neurite Growth Compounds as 5‑HT2A Agonists for Treating Stress-Related Disorders, Namely Depression, Anxiety, and PTSD. [PDF]
ACS Med Chem LettSabnis RW.
europepmc +1 more source
The working lives of neuronal 5-HT<sub>2A</sub> receptors from the outside in. [PDF]
RSC Chem BiolJabar A, Pinto M, Hébert TE.
europepmc +1 more source
Hypersomatotropism and Hypercortisolism Caused by a Plurihormonal Pituitary Adenoma in a Dog. [PDF]
J Vet Intern MedSoler Arias EA +3 more
europepmc +1 more source
A new and useful tool for differentiating prolactinomas from non-functioning pituitary adenomas: a pilot study of the cabergoline disconnection test. [PDF]
Einstein (Sao Paulo)Galliano SA +11 more
europepmc +1 more source